Chris Rubino

414 citations
17 papers · 334 indexed · h-index 7

Chris Rubino

17 papers receiving 318 citations

Peers

Chris Rubino
Comparison fields: 5 of 55
  • Clinical Biochemistry 59
  • Infectious Diseases 150
  • Applied Microbiology and Biotechnology 15
  • Molecular Medicine 30
  • Pharmacology 74
Replace Yasutaka Nakamura with:
Yasutaka Nakamura Japan
André Almeida Portugal
Tilman Lingscheid Germany
Takaoki Hirose Japan
A. Paul Vastola United States
Hari Polenakovik United States
Huang-Shen Lin Taiwan
Małgorzata Mikaszewska-Sokolewicz Poland
Nina Pastukh Israel
Roopali Sharma United States
Chris Rubino relative to Yasutaka Nakamura Japan Yasutaka Nakamura's profile →
Citations per field
00.5×1.5×2.4×
Yasutaka Nakamura · 1×
Citations per year

Countries citing papers authored by Chris Rubino

Since Specialization
Citations

This map shows the geographic impact of Chris Rubino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Rubino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Rubino more than expected).

Fields of papers citing papers by Chris Rubino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Rubino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Rubino. The network helps show where Chris Rubino may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Chris Rubino, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chris Rubino Line = papers co-authored together Chris Rubino links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1 20201
2 20191
3 20192
4 20163
5 20166
6 20152
7 20155
8 2015179
9 20156
10 201516
11 20141
12 201119
13 200972
14 200813
15 20032
16 20023
17 19993

About Chris Rubino

Chris Rubino is a scholar working on Applied Microbiology and Biotechnology, Cancer Research and Pharmacology, having authored 17 papers that have together received 334 indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Antifungal resistance and susceptibility (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers) and Organic and Inorganic Chemical Reactions (2 papers). The work is most often cited by research in Clinical Biochemistry (59 citations), Infectious Diseases (150 citations) and Applied Microbiology and Biotechnology (15 citations). Chris Rubino has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include James Baldassarre, Michael W. Dunne, Sailaja Puttagunta, Scott Van Wart, Paul G. Ambrose, Sujata M. Bhavnani, J. Loutit, Alan Forrest, William McCulloch and David E. Geller. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Journal of Allergy and Clinical Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026